Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura

August 23, 2016 updated by: Coloplast A/S

Investigating the Safety and Performance of Newly Developed 1-piece Ostomy Product Concept Compared With SenSura 1-piece in Subjects With an Ileostomy

The aim of the current investigation is to evaluate the combination of an adhesive with a soft top film.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Skövde, Sweden, 541 85
        • Skövde Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Be able to handle the bags themselves
  4. Have an ileostomy with a diameter between 15 and 55 mm
  5. Have had their ileostomy for at least 3 months
  6. Currently use a 1-piece flat ostomy appliance with open bag
  7. Use minimum 1 product every second day, i.e. maximum 2 days wear time
  8. Be suitable for participation in the study and for using a standard adhesive, flat base plate
  9. Must be able and willing to use custom cut products
  10. Accept to test two 1-piece products within the study period

Exclusion Criteria:

  1. Use irrigation during the study period (flush the intestines with water)
  2. Currently receiving or have within the past 2 months received chemotherapy or radiation therapy
  3. Currently receiving or have within the past month received systematic steroid or local treatment in the peristomal area
  4. Are pregnant or breastfeeding
  5. Participating in other interventional clinical investigations or have previously participated in this investigation
  6. Currently using a ostomy belt
  7. Currently using extended wear product
  8. Have a loop ileostomy
  9. Known hypersensitivity towards any of the test products
  10. Suffering from severe peristomal skin problems prior to participation in the investigation (assessed by the study nurse)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: First Test product; then SenSura

The subject in this arm first test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details.

After cross-over the subject test SenSura which is CE-marked and commerical available.

The test product consists of an adhesive with a new top film
SenSura is the CE-marked and commercially available comparator product
Active Comparator: First SenSura, Then Test product

The subject in this arm first test SenSura which is CE-marked and commerical available.

After cross-over the subject test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details.

The test product consists of an adhesive with a new top film
SenSura is the CE-marked and commercially available comparator product

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leakage (Percentage of All Baseplates With Leakage)
Time Frame: After each baseplate change over a period, of 7 days

leakage is measured using a 4-point leakage scale developed by Coloplast A/S. At every baseplate change the subjects had to look at the skin facing side of the baseplate and access which of the four scenarios described below provided an accurate description of the baseplate.

The subjects tick of one of the four possible answers:

  1. No leakage
  2. Starting to leak (leakage under the baseplate)
  3. Leakage (seepage of faeces resulting in leakage on clothes)
  4. Sudden leakage (the baseplate pops off resulting in sudden leakage under the baseplate and outside the baseplate)
After each baseplate change over a period, of 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

February 22, 2013

First Submitted That Met QC Criteria

February 22, 2013

First Posted (Estimate)

February 26, 2013

Study Record Updates

Last Update Posted (Estimate)

September 30, 2016

Last Update Submitted That Met QC Criteria

August 23, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CP237

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ileostomy - Stoma

Clinical Trials on Test product

Subscribe